This is reassuring from a clinical perspective, since there is evidence that IL-7 promotes T-ALL cell expansion in patients [44] and is known to confer resistance to other treatments, such as glucocorticoids [59,60]. Here, IL7 is linked to acute lymphoblastic leukemia.